Overall Technical outlook

Price Summary

On 2025-06-11, Suven Pharmaceuticals Limited's stock started at 1010.0, soared to 1024.9, dropped to 995.7, and finished the day -0.76% down at 1002.3, with a trading volume of 415296 shares.
The peak price for the stock in the past 52 weeks is 1334.2, with the lowest price being 699.3.
According to 6 analysts, the price of SUVENPHAR in the future is projected to be between 1290.0 and 1500.0, with an average expected price of 1396.6666.

Technicals

Support and Resistance: The price for SUVENPHAR at 1002.3 is supported by the 975.3 level and faces resistance at 1050.1. This range indicates key levels where the price may find buyers near 975.3 and sellers near 1050.1, defining a trading range.
SUVENPHAR supportResistance ae98a8
Support/Resistance for SUVENPHAR


Aroon: The continuation of Aroon's bearish trend, with Aroon Down still at the 100 level, indicates strong bearish pressure. However, further analysis with additional indicators is essential to better understand the trend's potential impact on the market.
SUVENPHAR aroon ae98a8
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
SUVENPHAR bbands ae98a8
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bearish, reinforcing a resistance level that could restrict any upward movement. This resistance indicates that the market may remain under bearish control, with limited potential for gains.
SUVENPHAR psar ae98a8
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The Stochastic K-line's descent below the D-line and under 20 suggests a mildly bearish outlook for SUVENPHAR. This indicates that the market may face some pressure to the downside, though the bearish tone is moderate. Investors should consider this as a potential early warning sign.
SUVENPHAR stoch ae98a8
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The 20-50-100 period moving averages are aligned in a bullish formation for Suven Pharmaceuticals Limited, though caution is advised as the slopes of the shorter-term averages indicate a possible reversal ahead. While the trend remains upward, the weakening momentum in the faster-moving averages suggests that a shift in direction could be on the horizon.
SUVENPHAR trippleSMA ae98a8
Tripple SMA chart for Suven Pharmaceuticals Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.